Nooruddin Shaik 2023. A Critical Review of Cinqair (Reslizumab) in the Treatment of Severe Asthma Patients. Future Journal of Pharmaceuticals and Health Sciences. 3, 2 (May 2023), 126–133. DOI:https://doi.org/10.26452/fjphs.v3i2.442.